Integer Holdings Co. (NYSE:ITGR – Get Rating) CEO Joseph W. Dziedzic purchased 4,000 shares of Integer stock in a transaction dated Friday, December 16th. The stock was acquired at an average cost of $61.95 per share, with a total value of $247,800.00. Following the completion of the acquisition, the chief executive officer now directly owns 122,378 shares in the company, valued at $7,581,317.10. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Integer Stock Performance

NYSE ITGR opened at $62.80 on Friday. Integer Holdings Co. has a 1-year low of $50.05 and a 1-year high of $88.58. The company has a market capitalization of $2.08 billion, a P/E ratio of 29.21 and a beta of 1.17. The business has a 50 day moving average price of $65.50 and a 200 day moving average price of $67.31. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.80 and a quick ratio of 1.74.

Integer (NYSE:ITGR – Get Rating) last released its quarterly earnings data on Thursday, October 27th. The medical equipment provider reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.06. Integer had a return on equity of 9.24% and a net margin of 5.47%. The firm had revenue of $342.68 million during the quarter, compared to the consensus estimate of $343.15 million. Sell-side analysts expect that Integer Holdings Co. will post 3.78 EPS for the current fiscal year.

Hedge Funds Weigh In On Integer

Analyst Ratings Changes

Several analysts have recently commented on ITGR shares. Benchmark reduced their price target on Integer to $90.00 in a report on Tuesday, November 1st. KeyCorp reduced their price target on Integer from $97.00 to $84.00 and set an "overweight" rating for the company in a report on Thursday, October 6th. Finally, StockNews.com started coverage on Integer in a report on Wednesday, October 12th. They issued a "hold" rating for the company.

About Integer

(Get Rating)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.

Read More

• Get a free copy of the StockNews.com research report on Integer (ITGR)
• MarketBeat: Week in Review 12/12 – 12/16
• Which Two Bluechip Tech Companies Have Raised Their Guidance?
• Should You Worry About Elon Musk Selling His Tesla Shares?
• Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
• This is no Time to Buy Lennar but the Time is Coming

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.